促红细胞生成素治疗期间功能性缺铁的检测：一种新方法。 - Suppr

Suppr

超能文献

Detection of functional iron deficiency during erythropoietin treatment: a new approach.

作者信息

Macdougall I C, Cavill I, Hulme B, Bain B, McGregor E, McKay P, Sanders E, Coles G A, Williams J D

机构信息

Department of Nephrology, St Bartholomew's Hospital, London.

出版信息

BMJ. 1992 Jan 25;304(6821):225-6. doi: 10.1136/bmj.304.6821.225.

DOI:10.1136/bmj.304.6821.225

PMID:1739797

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1881474/

Abstract

摘要

相似文献

Detection of functional iron deficiency during erythropoietin treatment: a new approach.促红细胞生成素治疗期间功能性缺铁的检测：一种新方法。

BMJ. 1992 Jan 25;304(6821):225-6. doi: 10.1136/bmj.304.6821.225.

Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.与血液透析患者相比，腹膜透析患者对促红细胞生成素的反应改善：缺铁的作用。

Adv Perit Dial. 1994;10:135-8.

Iron deficiency during erythropoietin therapy in haemodialysis patients.

Nephrol Dial Transplant. 1994;9(6):735-6. doi: 10.1093/ndt/9.6.735.

Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.成熟红细胞参数作为血液透析中功能性缺铁的新标志物：敏感性和特异性

Nephrol Dial Transplant. 2007 Apr;22(4):1156-62. doi: 10.1093/ndt/gfl765. Epub 2007 Jan 20.

Factors determining the percentage of hypochromic red blood cells in hemodialysis patients.决定血液透析患者低色素红细胞百分比的因素。

Kidney Int. 1999 Sep;56(3):1113-9. doi: 10.1046/j.1523-1755.1999.00627.x.

[The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].[血液透析和持续性非卧床腹膜透析对肾性贫血的影响]

Srp Arh Celok Lek. 1997 May-Jun;125(5-6):163-7.

Erythropoietin and iron.促红细胞生成素与铁

Clin Nephrol. 1997 Mar;47(3):141-57.

Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency.口服补充维生素C可降低功能性缺铁血液透析患者的促红细胞生成素需求量。

Int Urol Nephrol. 2016 Sep;48(9):1519-24. doi: 10.1007/s11255-016-1309-9. Epub 2016 May 11.

Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.肾性贫血中铁缺乏的管理：促红细胞生成素治疗患者最佳治疗方法指南

Clin Nephrol. 1997 Jul;48(1):1-8.

Comparison of magnesium and zinc levels in blood in end stage renal disease patients treated by hemodialysis or peritoneal dialysis.接受血液透析或腹膜透析治疗的终末期肾病患者血液中镁和锌水平的比较。

Magnes Res. 2002 Dec;15(3-4):229-36.

引用本文的文献

Mean Corpuscular Volume Is Not a Reliable Predictor of Iron Deficiency in Patients With Chronic Kidney Disease: A Post-Hoc Analysis of the BRIGHTEN Trial.平均红细胞体积并非慢性肾脏病患者缺铁的可靠预测指标：BRIGHTEN试验的事后分析

Cureus. 2025 Apr 28;17(4):e83159. doi: 10.7759/cureus.83159. eCollection 2025 Apr.

Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension.低色素红细胞对肺动脉高压患者预后的影响。

Respir Res. 2021 Nov 9;22(1):288. doi: 10.1186/s12931-021-01884-9.

British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults.英国胃肠病学会成人缺铁性贫血管理指南。

Gut. 2021 Nov;70(11):2030-2051. doi: 10.1136/gutjnl-2021-325210. Epub 2021 Sep 8.

Heterogeneity of Red Blood Cells: Causes and Consequences.红细胞的异质性：原因与后果

Front Physiol. 2020 May 7;11:392. doi: 10.3389/fphys.2020.00392. eCollection 2020.

Measurement of iron status in chronic kidney disease.慢性肾脏病中铁状态的测定。

Pediatr Nephrol. 2019 Apr;34(4):605-613. doi: 10.1007/s00467-018-3955-x. Epub 2018 Apr 17.

Markers of iron status in chronic kidney disease.慢性肾脏病中铁状态的标志物

Hemodial Int. 2017 Jun;21 Suppl 1(Suppl 1):S21-S27. doi: 10.1111/hdi.12556. Epub 2017 Mar 22.

Laboratory and genetic assessment of iron deficiency in blood donors.献血者缺铁的实验室及基因评估

Clin Lab Med. 2015 Mar;35(1):73-91. doi: 10.1016/j.cll.2014.10.011. Epub 2014 Nov 5.

Erythrocyte and Reticulocyte Indices on the LH 750 as Potential Markers of Functional Iron Deficiency.LH 750上的红细胞和网织红细胞指数作为功能性缺铁的潜在标志物

Anemia. 2010;2010:625919. doi: 10.1155/2010/625919. Epub 2010 Jun 16.

Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood.骨髓铁幼粒细胞性改变可通过外周血红细胞计数预测。

Int J Lab Hematol. 2010 Jun;32(3):329-35. doi: 10.1111/j.1751-553X.2009.01185.x. Epub 2009 Aug 25.

Iron therapy for renal anemia: how much needed, how much harmful?肾性贫血的铁剂治疗：需要多少，危害几何？

Pediatr Nephrol. 2007 Apr;22(4):480-9. doi: 10.1007/s00467-006-0405-y. Epub 2007 Jan 6.

本文引用的文献

Disorders of iron metabolism. Diagnostic methods.

Clin Haematol. 1982 Jun;11(2):259-73.

Evaluation of iron status in patients on chronic hemodialysis: relative usefulness of bone marrow hemosiderin, serum ferritin, transferrin saturation, mean corpuscular volume and red cell protoporphyrin.慢性血液透析患者铁状态的评估：骨髓含铁血黄素、血清铁蛋白、转铁蛋白饱和度、平均红细胞体积和红细胞原卟啉的相对效用

Nephron. 1983;35(3):196-200. doi: 10.1159/000183074.

Iron status in patients receiving erythropoietin for dialysis-associated anemia.接受促红细胞生成素治疗透析相关性贫血患者的铁状态

Kidney Int. 1989 Feb;35(2):712-6. doi: 10.1038/ki.1989.43.

USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients.美国使用重组人促红细胞生成素（安进公司）的多中心临床试验。血液透析患者的试验结果。

Contrib Nephrol. 1989;76:160-5; discussion 212-8. doi: 10.1159/000417892.

Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously.静脉注射铁剂纠正了肾性贫血对促红细胞生成素治疗反应不佳的情况。

BMJ. 1989 Jul 15;299(6692):157-8. doi: 10.1136/bmj.299.6692.157.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验